Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Assistant Professor
|Clinical Utility of PARIS Score for the Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Multi-center Registry
|The 81st Annual Scientific Meeting of the Japanese Circulation Society (JCS2017)
|Japanese Circulation Society
|Publisher and common publisher
|◎HATA Takehiro, OOTSUKI Hisao, TANAKA Kazuki, NAKAO Masashi, KADOWAKI Hiromu, SHIMAZAKI Kensuke, JUJO Kentaro, ARASHI Hiroyuki, SAITO Katsumi, TAKAGI Atsushi, OOTA Yoshimi, FUJII Shinya, TANAKA Hiroyuki, HONDA Atsushi, MORI Fumiaki, YAMAGUCHI Junichi, OGAWA Hiroshi, HAGIWARA Nobuhisa
(city and name of the country)
|PROGRAM JCS 2017 210
|Background: PARIS Score is a risk stratification score set from PARIS registry. It can predict thrombotic and bleeding event separately for the patients with percutaneous coronary intervention (PCI). However, there is no validation data of PARIS Score in patients with atrial fibrillation (AF) undergoing PCI.
Methods and Results: Consecutive 592 patients with AF underwent PCI during 2011 to 2014 were registered at 8 medical centers. Among them 35 patients were excluded because of missing data for PARIS Score. Finally, 557 patients were enrolled in this study. The incidence of major adverse cerebro-cardiovascular events (MACCE) and bleeding complications were evaluated. Baseline characteristics and Kaplan-Meier analyses of clinical outcomes are shown below. Conclusion: PARIS Score might be able to evaluate the thrombotic and bleeding risk in patients with AF undergoing PCI.